Cargando…
The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative transurethral resection of the prostate (pTURP) surgery. Methods: We identified patients with mPCa between 2004 and 2016 in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586220/ https://www.ncbi.nlm.nih.gov/pubmed/34778357 http://dx.doi.org/10.3389/fsurg.2021.726534 |
_version_ | 1784597849471713280 |
---|---|
author | Fang, Kun Song, Pan Zhang, Jiahe Yang, Luchen Liu, Peiwen Lu, Ni Dong, Qiang |
author_facet | Fang, Kun Song, Pan Zhang, Jiahe Yang, Luchen Liu, Peiwen Lu, Ni Dong, Qiang |
author_sort | Fang, Kun |
collection | PubMed |
description | Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative transurethral resection of the prostate (pTURP) surgery. Methods: We identified patients with mPCa between 2004 and 2016 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients who received pTURP and non-surgical therapy were identified. A propensity-score matching was introduced to balance the covariate. Kaplan–Meier analysis and COX regression were conducted to evaluate the overall survival (OS) and cancer-specific survival (CSS) outcomes. Results: A total of 36,003 patients were identified; 2,823 of them were in the pTURP group and 33,180 were in the non-surgical group. The survival curves of the overall cohort showed that the pTURP group was associated with worse outcomes in both OS (HR: 1.12, 95% CI: 1.07–1.18, p < 0.001) and CSS (HR: 1.08, 95% CI: 1.02–1.15, p = 0.004) compared with the non-surgical group. The mean survival time in the overall cohort of the pTURP group was shorter than the non-surgical group in both OS [35.13 ± 1.53 vs. 40.44 ± 0.59 months] and CSS [48.8 ± 1.27 vs. 55.92 ± 0.43 months]. In the matched cohort, the pTURP group had significantly lower survival curves for both OS (HR: 1.25, 95% CI: 1.16–1.35, p < 0.001) and CSS (HR: 1.23, 95% CI: 1.12–1.35, p < 0.001) than the non-surgical group. pTURP significantly reduced the survival months of the patients (36.49 ± 0.94 vs. 45.52 ± 1.23 months in OS and 50.1 ± 1.49 vs. 61.28 ± 1.74 months in CSS). In the multivariate COX analysis, pTURP increased the risk of overall mortality (HR: 1.19, 95% CI: 1.09–1.31, p < 0.001) and cancer-specific mortality CSS (HR: 1.23, 95% CI: 1.14–1.33, p < 0.001) compared with the non-surgical group. Conclusions: For mPCa patients with BOO, pTURP could reduce OS and CSS while relieving the obstruction. |
format | Online Article Text |
id | pubmed-8586220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85862202021-11-13 The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study Fang, Kun Song, Pan Zhang, Jiahe Yang, Luchen Liu, Peiwen Lu, Ni Dong, Qiang Front Surg Surgery Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative transurethral resection of the prostate (pTURP) surgery. Methods: We identified patients with mPCa between 2004 and 2016 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients who received pTURP and non-surgical therapy were identified. A propensity-score matching was introduced to balance the covariate. Kaplan–Meier analysis and COX regression were conducted to evaluate the overall survival (OS) and cancer-specific survival (CSS) outcomes. Results: A total of 36,003 patients were identified; 2,823 of them were in the pTURP group and 33,180 were in the non-surgical group. The survival curves of the overall cohort showed that the pTURP group was associated with worse outcomes in both OS (HR: 1.12, 95% CI: 1.07–1.18, p < 0.001) and CSS (HR: 1.08, 95% CI: 1.02–1.15, p = 0.004) compared with the non-surgical group. The mean survival time in the overall cohort of the pTURP group was shorter than the non-surgical group in both OS [35.13 ± 1.53 vs. 40.44 ± 0.59 months] and CSS [48.8 ± 1.27 vs. 55.92 ± 0.43 months]. In the matched cohort, the pTURP group had significantly lower survival curves for both OS (HR: 1.25, 95% CI: 1.16–1.35, p < 0.001) and CSS (HR: 1.23, 95% CI: 1.12–1.35, p < 0.001) than the non-surgical group. pTURP significantly reduced the survival months of the patients (36.49 ± 0.94 vs. 45.52 ± 1.23 months in OS and 50.1 ± 1.49 vs. 61.28 ± 1.74 months in CSS). In the multivariate COX analysis, pTURP increased the risk of overall mortality (HR: 1.19, 95% CI: 1.09–1.31, p < 0.001) and cancer-specific mortality CSS (HR: 1.23, 95% CI: 1.14–1.33, p < 0.001) compared with the non-surgical group. Conclusions: For mPCa patients with BOO, pTURP could reduce OS and CSS while relieving the obstruction. Frontiers Media S.A. 2021-10-29 /pmc/articles/PMC8586220/ /pubmed/34778357 http://dx.doi.org/10.3389/fsurg.2021.726534 Text en Copyright © 2021 Fang, Song, Zhang, Yang, Liu, Lu and Dong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Fang, Kun Song, Pan Zhang, Jiahe Yang, Luchen Liu, Peiwen Lu, Ni Dong, Qiang The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study |
title | The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study |
title_full | The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study |
title_fullStr | The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study |
title_full_unstemmed | The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study |
title_short | The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study |
title_sort | impact of palliative transurethral resection of the prostate on the prognosis of patients with bladder outlet obstruction and metastatic prostate cancer: a population-matched study |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586220/ https://www.ncbi.nlm.nih.gov/pubmed/34778357 http://dx.doi.org/10.3389/fsurg.2021.726534 |
work_keys_str_mv | AT fangkun theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT songpan theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT zhangjiahe theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT yangluchen theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT liupeiwen theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT luni theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT dongqiang theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT fangkun impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT songpan impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT zhangjiahe impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT yangluchen impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT liupeiwen impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT luni impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy AT dongqiang impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy |